Published · 8 November 2026
Evidence reviewed 8 November
02 / 09The public argument
Sources & notes ↗
0221:05 · News beside the menu

A return policy cannot
calibrate a sensor.

Chapter 2 of 9 · About 4 minutes
Follow the day

The founder is talking about a product proving useful in people’s hands. The doctors are asking how its measurements were validated. These questions can both matter; a return policy cannot answer the second one on its own.

Why are doctors questioning Deepinder Goyal’s Temple?

The November 2026 exchange concerns whether Temple’s measurements and broader health claims have adequate independent validation. Goyal’s defence points to commitment, customer choice and further studies; the doctors ask for evidence they can scrutinise. This chapter attributes those positions and keeps allegations separate from established findings. Read the three voices here, then follow the measurement evidence in the research chapter.[2][3][4]

Before leaving the restaurant, Mira opens the argument everyone seems to be having. Temple, reported at ₹85,000 for pre-booking, has become a dispute about what a small device at the side of the head can establish. On 5 November 2026, Goyal defended the project on X, citing its investment, his personal commitment and a fourteen-day return policy. In coverage published the following day, he described it as a fitness and wellness device rather than a medical device.[2][3]

Dr Rishabh Jain’s response separated consumer satisfaction from scientific validation. Dr Cyriac Abby Philips, known as The Liver Doc, challenged the brain-health claims more broadly. Their posts are part of the public record of the disagreement; they are not themselves experimental tests. Goyal’s commercial argument and the doctors’ evidentiary demands concern different questions, even when the exchange makes them sound like competing answers to the same one.[3][4]

The public exchange · Read without leaving the story

Three voices, different standards of evidence

Swipe between the cards or use the arrows. Each begins with an editorial paraphrase checked against dated reporting. “Read the original here” loads that post from X inside this page; it is optional and may depend on X being available.

1 / 3
5 November 2026

Deepinder Goyal

@deepigoyal · The founder’s defence

Goyal points to the team’s investment, his own commitment, the return window and expected independent studies. His case is that Temple deserves a chance to demonstrate value in use. Those are reasons to examine the product; they do not independently establish measurement accuracy.

Editorial paraphrase, not a quotation. Dated reporting used for verification.

Original permalink on X ↗
6 November 2026

Dr Cyriac Abby Philips

@theliverdoc · The claim needs scientific scrutiny

Philips challenges the scientific basis and marketing of Temple’s brain-health claims, focusing on what the device can establish about cerebral circulation and broader health interpretation. His stronger allegations remain his assertions; this article evaluates the published evidence rather than adopting them as findings.

Editorial paraphrase, not a quotation. Dated reporting used for verification.

Original permalink on X ↗
5 November 2026

Dr Rishabh Jain

@DrRishabhOnco · Satisfaction and validation differ

Jain asks for scientific evidence that can be examined independently. Personal sacrifice, reputation, investment and a customer return policy do not establish the accuracy of a health-related measurement. A person enjoying a device and a study validating its output answer different questions.

Editorial paraphrase, not a quotation. Dated reporting used for verification.

Original permalink on X ↗
Three questions, three kinds of evidence

Does it measure?

Compare the output with a suitable reference, specify the quantity and units, and establish error, repeatability and the conditions under which it works.

Does it help?

Test whether using the information changes decisions or outcomes that matter. Enjoying a device, understanding a reading and benefiting from it are distinguishable results.

A return policy can reduce a buyer’s financial risk. It cannot independently establish the anatomical source or accuracy of a signal.

At the restaurant, Mira could send back a disappointing meal. That would tell us something about her satisfaction, but little about whether the kitchen’s thermometer was calibrated. Conversely, a correctly calibrated thermometer would not guarantee that she enjoyed dinner. The distinction gives both innovation and criticism room to be serious: preliminary experiments deserve examination, while investment and enthusiasm cannot carry a claim further than the measurements support.

The dispute also contains an invitation to overreach. An absence of established clinical benefit does not prove a device has no possible use, just as an interesting signal does not prove a longevity claim. This inquiry therefore leaves the loudest allegations aside and asks what the published comparisons actually tested. Mira closes her laptop and goes home; tomorrow, an ordinary change in her pulse will make the difference between a measurement and its interpretation much harder to ignore.